Amicus Therapeutics, Inc. (FOLD)
14.33
+0.02
(+0.14%)
USD |
NASDAQ |
Jan 16, 16:00
14.32
-0.01
(-0.07%)
After-Hours: 20:00
Amicus Therapeutics EPS Diluted (Quarterly): 0.0558 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| CorMedix, Inc. | 1.259 |
| Krystal Biotech, Inc. | 2.660 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Ekso Bionics Holdings, Inc. | -0.5432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.31M |
| Revenue (Quarterly) | 169.06M |
| Total Expenses (Quarterly) | 151.76M |
| Enterprise Value | 4.600B |
| Gross Profit Margin (Quarterly) | 87.38% |
| Profit Margin (Quarterly) | 10.24% |
| Earnings Yield | -0.31% |
| Operating Earnings Yield | 0.79% |
| Normalized Earnings Yield | -0.2854 |